Non-Pulmonary Vein Substrate Ablation of Recurrent Atrial Fibrillation in the Patient With Fabry Disease

Area of Science:

• Cardiology
• Electrophysiology
• Genetics

Background:

• Fabry disease (FD) is a rare genetic disorder.
• FD leads to progressive myocardial degeneration, affecting heart function.
• Atrial fibrillation (AF) is a common complication in FD patients.

Purpose of the Study:

• To investigate the electrophysiological substrate in the left atrium of FD patients with AF.
• To evaluate the potential efficacy of non-pulmonary vein (non-PV) substrate ablation in this population.

Main Methods:

• Electroanatomical mapping of the left atrium.
• Analysis of voltage and potential fractionation in FD patients with AF.
• Comparison with control groups (if applicable).

Main Results:

• FD patients with AF exhibit distinct patterns, including limited low-voltage areas.
• Presence of fractionated potentials in the left atrium of FD patients with AF.
• These findings suggest an arrhythmogenic substrate beyond pulmonary veins.

Conclusions:

• The specific left atrial substrate in FD patients with AF warrants further investigation.
• Non-pulmonary vein substrate ablation may be a viable therapeutic strategy for AF management in FD.
• Targeting non-PV areas could improve outcomes for FD patients experiencing AF.